US chip curbs give Huawei a chance to fill the Nvidia void in China
By Josh Ye HONG KONG (Reuters) -U.S. measures to limit the export of advanced artificial intelligence (AI) chips to China may create an opening
U.S. chip export ban is ‘great news,’ says partner at Chinese tech investment fund
A partner at a Chinese semiconductor investment fund has welcomed the U.S. government’s ban of certain advanced chip types to be exported to China,
Chinese drug firms backed by global banks found using leopards and pangolins parts, group says
Editor’s Note: Sign up for CNN’s Meanwhile in China newsletter which explores what you need to know about the country’s rise and how it
United Therapeutics Shifts Focus To Tyvaso DPI Amidst Generic Threat (NASDAQ:UTHR)
At a Glance United Therapeutics’ (NASDAQ:UTHR) Q2 performance underscores robust financials with a notable 27.7% YoY revenue increase, fueling investor optimism. On the clinical
Defense Secretary Austin says US is ‘concerned about potential escalation’ in Middle East
US Secretary of Defense Lloyd Austin said Sunday the US is “concerned about potential escalation” in the Middle East a day after announcing the
A Huge Bank Doubled Down on NIO Stock. It Sold Intel, Salesforce, and Disney.
The asset manager of Norway’s largest bank just made big changes in its U.S.-traded stock portfolio, including more than doubling a position in a
Venezuela is set for a ‘long journey’ to boost oil output if U.S. eases sanctions
A lifting of U.S. sanctions on Venezuelan oil would lead to more oil on the global markets but mark the start of a “long
Asia shares slip on Middle East woes, higher yields
By Wayne Cole SYDNEY (Reuters) – Asian shares hit one-year lows Monday as the risk of a wider conflict in the Middle East clouded
The Netherlands named the best place to retire — here’s how other countries compare
Retirement income systems vary in different countries, and the U.S. does not come out on top. Klaus Vedfelt | Digitalvision | Getty Images Long-awaited
Swiss pharma giant Roche agrees $7.1 billion deal to buy Telavant Holdings
Swiss health care company Roche on Monday announced it would acquire Telavant Holdings in a $7.1 billion transaction. Telavant produces drugs for people suffering
Most Read
